All articles tagged with #advisory committee
Originally Published 3 months ago — by The Washington Post
The article discusses tensions within the CDC's Advisory Committee on Immunization Practices, highlighting concerns about their understanding of process and reliance on flawed research during discussions on COVID, hepatitis B, and MMRV vaccines, amid broader conflicts about science under RFK Jr.
Originally Published 3 months ago — by The Guardian
A US CDC advisory committee voted against recommending prescriptions for Covid vaccines, emphasizing individual decision-making and informed consent, amidst debates and divisions over vaccine safety and policy, which could impact vaccine access and coverage.
Originally Published 3 months ago — by NBC News
CDC vaccine advisors decided not to delay the hepatitis B vaccine for newborns despite discussions about potential side effects and safety concerns, reaffirming the vaccine's importance in preventing hepatitis B infections from mother to child.
Originally Published 3 months ago — by CNN
A US CDC vaccine advisory committee is set to meet and potentially make significant changes to the childhood vaccine schedule, amid controversy over new members appointed by vaccine skeptic Robert F. Kennedy Jr. The meeting will focus on COVID-19 vaccine recommendations, hepatitis B vaccination policies, and other immunization issues, with concerns about politicization and scientific integrity influencing the process.
Originally Published 7 months ago — by The New York Times
U.S. health secretary Robert F. Kennedy Jr. dismissed all 17 members of the CDC's immunization advisory committee, citing a need to restore public trust in vaccines, as the panel influences vaccine recommendations and coverage decisions.
Originally Published 2 years ago — by NBC Sports
Commanders owner Josh Harris has announced the formation of a small advisory committee, including former Vikings GM Rick Spielman and former Golden State Warriors GM Bob Myers, to assist in the hiring of a new head coach and head of football operations following the firing of Ron Rivera. Harris emphasized the importance of finding the right candidates to lead the franchise forward after a challenging 4-13 season, acknowledging the significant rebuilding job ahead for the team.
Originally Published 2 years ago — by Endpoints News
The FDA's Cardiovascular and Renal Drugs Advisory Committee voted 9-3 in favor of Alnylam Pharmaceuticals' Onpattro for the treatment of ATTR cardiomyopathy, with panelists agreeing that the benefits outweigh the risks. While acknowledging the limited benefits, committee members expressed hope that clinicians would counsel patients on this treatment option.
Originally Published 2 years ago — by Barron's
Sarepta Therapeutics' shares fell after a report from STAT revealed that the FDA had planned to reject the company's application for approval of its gene therapy to treat Duchenne muscular dystrophy without holding an advisory committee meeting. However, Dr. Peter Marks, the top FDA official, intervened and scheduled the hearing, leading to uncertainty about the approval of the gene therapy.
Originally Published 2 years ago — by Investor's Business Daily
Sarepta Therapeutics' stock crashed nearly 20% after the FDA announced it would hold an advisory committee to discuss the risks and benefits of its gene therapy for Duchenne muscular dystrophy, despite the company's belief that it had met the requirements for accelerated approval. The FDA's decision to hold the advisory committee meeting before the May 29 approval decision date has raised concerns about a potential extension of the approval date. However, some analysts remain optimistic about the potential for Sarepta's gene therapy to ultimately gain approval.
Originally Published 2 years ago — by The Associated Press
San Francisco supervisors are considering paying reparations to Black people, but have not yet decided on the form of payment. The idea of Black reparations is not new, but movements began spreading across the country after George Floyd's death in 2020. Supporters argue that decades of racist policies and laws have systemically denied Black Americans access to property, education, and the ability to build generational wealth. Critics say it is not fair for municipal taxpayers to shoulder the cost of structural racism and discriminatory government policies. The advisory committee has made over 100 recommendations, including education, health, and job opportunities, but it is not clear how San Francisco will finance its atonement and repair.